IRIS
GRAVINA, Antonietta Gerarda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.255
NA - Nord America 2.021
AS - Asia 244
SA - Sud America 13
AF - Africa 5
OC - Oceania 3
Totale 4.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.012
IE - Irlanda 792
IT - Italia 483
UA - Ucraina 247
GB - Regno Unito 234
DE - Germania 145
CN - Cina 142
FR - Francia 82
SE - Svezia 81
FI - Finlandia 68
GR - Grecia 48
TR - Turchia 43
PL - Polonia 24
VN - Vietnam 24
BE - Belgio 15
IN - India 13
NL - Olanda 12
BR - Brasile 10
PK - Pakistan 10
RU - Federazione Russa 10
CA - Canada 7
AT - Austria 6
IR - Iran 4
SN - Senegal 4
AU - Australia 3
MK - Macedonia 3
ES - Italia 2
JP - Giappone 2
MX - Messico 2
AR - Argentina 1
BF - Burkina Faso 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
HK - Hong Kong 1
ID - Indonesia 1
KR - Corea 1
MY - Malesia 1
PH - Filippine 1
SG - Singapore 1
Totale 4.541
Salva come PNG Salva come JPEG
Città #
Dublin 789
Chandler 417
Jacksonville 376
Princeton 98
Naples 93
New York 86
Roxbury 79
Ann Arbor 66
Beijing 60
Cambridge 56
Bremen 53
Medford 48
Wilmington 44
Boardman 42
Woodbridge 39
Caserta 30
Dong Ket 24
Kraków 24
Des Moines 23
Nanjing 22
San Mateo 20
Napoli 19
Mountain View 18
Boydton 15
Brussels 15
Ashburn 13
Jinan 11
Shenyang 10
Milan 9
Rome 9
Atella 8
Sennori 8
Amsterdam 7
Houston 7
Norwalk 7
Porto Alegre 7
Auburn Hills 6
Lahore 6
Lappeenranta 6
Paris 6
Seregno 6
Vienna 6
Aversa 5
Bacoli 5
Brighton 5
Lanzhou 5
Pomezia 5
Cattolica 4
Hangzhou 4
Helsinki 4
Hyderabad 4
Lübeck 4
Mumbai 4
Salerno 4
Torre Annunziata 4
Atlanta 3
Bisaccia 3
Changsha 3
Düsseldorf 3
Guangzhou 3
Kunming 3
Lodi 3
Munich 3
Nanchang 3
Nola 3
Panettieri 3
Portici 3
Seattle 3
Serino 3
Vasto 3
Arnhem 2
Berlin 2
Casoria 2
Catania 2
Changchun 2
Chicago 2
Civitavecchia 2
Colomiers 2
Erding 2
Forlì 2
Gatchina 2
Haikou 2
Hanover 2
Hebei 2
Jiaxing 2
Kolkata 2
Marano Di Napoli 2
Mexico 2
Miami 2
Nerviano 2
Ningbo 2
Padova 2
Pavia 2
Perm 2
Pistoia 2
Pompei 2
Redwood City 2
San Giovanni Lupatoto 2
Scafati 2
Tianjin 2
Totale 2.850
Salva come PNG Salva come JPEG
Nome #
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 100
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 99
Intrafamilial spread of Helicobacter pylori infection 88
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 72
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 70
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 70
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 70
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 70
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 67
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 67
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 66
Caso di interferenza tra video capsula e pacemaker in paziente portatore di pacemaker per aritmia 66
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 64
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 63
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 63
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 62
The burden of anaemia in patients with inflammatory bowel diseases 62
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 62
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 60
Crohn’s disease and skin 59
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 59
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. 58
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 57
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 56
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 55
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 54
CARDIAC PACEMAKER AND WIRELESS CAPSULE ENDOSCOPY INTERFERENCE: CASE REPORT IN A PATIENT WITH GASTRIC VASCULAR ECTASIAS 54
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 53
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 53
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and Females 53
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 52
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 51
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 50
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 50
Diffusione intrafamiliare dell’infezione da Helicobacter pylori. 48
Infezione da Helicobacter pylori: fisiopatologia e clinica 48
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 48
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 48
Prevalence of lesions detected at upper endoscopy: an Italian Survey. 47
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 47
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 47
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments 46
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 46
Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa 45
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 45
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 44
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 43
Levofloxacin-containing quadruple concomitant therapy for eradication of H. pylori infection. 43
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin 43
Eradication of Helicobacter pylori infection: which regimen first? 42
Levofloxacin-based sequential therapy vs clarithromycin-based sequential therapy for eradication of H. pylori infection. 42
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 41
COELIAC DISEASE AND C VIRUS-RELATED CHRONIC HEPATITIS: A NON ASSOCIATION 41
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 41
Pyoderma gangrenosum: an updated review 38
The role of Helicobacter pylori infection and small intestinal bacterial overgrowth in rosacea 38
Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation 38
A randomized controlled trial of acarbose in hepatic encephalopathy 38
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 37
Cyclic vomiting in a young patient with superior mesenteric artery syndrome 37
Five-Day Quadruple Concomitant Therapy vs Ten-Day Sequential Therapy for Eradication of H. pylori Infection. 36
INTERFERENCE BETWEEN PACEMAKER AND VIDEO CAPUSLE ENDOSCOPY: CASE REPORT 36
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 36
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 35
Inflammatory Bowel Diseases: The Role of Gut Microbiota 35
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 35
Performance of a multi-compounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease 35
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 34
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 34
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 33
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 32
Light alcohol drinking and the risk of cancer development: a controversial relationship 32
Colonic angiodysplasia with adenomatous epithelial foci 31
Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient 31
Fourteen-day, high-dose acid suppression, non-bismuth quadruple therapies (“hybrid” vs. “concomitant”) for Helicobacter pylori eradication: a randomised trial 31
Levofloxacin-based sequential therapy for eradication of H. pylori infection. 31
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 31
Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets 31
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 31
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 31
Cycloxygenase-2 and vascular endothelial growth factor expression in ileal pouch anal anastomosis. 30
Does gender influence upper gastrointestinal symptoms and endoscopic diagnosis? 30
Gender difference in dermatological adverse effects during antibodies anti-TNFα therapy in chronic inflammatory bowel disease 30
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 30
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 29
Five-day quadruple concomitant therpy vs ten-day sequential therapy for eradication of H. pylori infection. 29
Optimized non-bismuth quadruple therapies cure most patients infected with Helicobacter pylori despite resistance to Clarithromycin and Metronidazole 29
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study 28
Prevalence of nonpolypoid colorectal neoplasia: an Italian multi center observational study 27
Second-Line Rescue Therapy With Moxifloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection 27
Studio della flora microbica intestinale 27
The “three-in-one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice 27
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 27
Fat: a matter of disturbance for the immune system 26
Helicobacter pylori and extragastric diseases: A review 26
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 25
Liver failure in an obese middle-aged woman after biliointestinal by pass 25
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 24
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 22
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 21
Totale 4.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 9 8 8
2019/2020417 81 76 11 6 59 13 80 21 22 17 25 6
2020/2021638 58 10 67 36 90 13 86 58 15 88 75 42
2021/2022729 31 5 8 32 187 9 53 22 33 44 112 193
2022/20231.642 129 57 30 149 195 122 11 105 758 20 35 31
2023/2024609 56 37 43 62 231 110 26 17 7 20 0 0
Totale 4.725